The Short Version
Novo Nordisk is indeed facing Ozempic-related lawsuits, but the evidence does not show a single lawsuit seeking US$2 billion in damages. The "$2 billion" figure is reported as an aggregate estimate of potential liability or payouts across many cases, not as the demand in one specific complaint. The claim is therefore not supported as stated.